Bio-polyamide Market Size, Share & Trends Analysis Report By Product (PA-6, PA-66, Specialty Polyamides), By Application (Fiber, Engineering Plastics), By End Use (Textile, Automotive, Film & Coating), By Region, And Segment Forecasts, 2025 - 2030

Bio-polyamide Market Size, Share & Trends Analysis Report By Product (PA-6, PA-66, Specialty Polyamides), By Application (Fiber, Engineering Plastics), By End Use (Textile, Automotive, Film & Coating), By Region, And Segment Forecasts, 2025 - 2030

U.S. DHA Market Size & Trends

The U.S. DHA market size was estimated at USD 352.11 million in 2024 and is projected to grow at a CAGR of 5.2% from 2025 to 2030. The market growth is primarily driven by increasing consumer awareness of the health benefits associated with omega-3 fatty acids. As more individuals recognize the importance of these nutrients for brain and heart health, the demand for DHA-rich products has surged. This trend is particularly evident in the dietary supplement sector, where consumers are actively seeking natural solutions to enhance their well-being.

The dietary supplement sector plays a crucial role in this demand as more individuals seek natural solutions to enhance their well-being. In addition, the incorporation of omega-3s into functional foods and beverages is expanding, catering to health-conscious consumers looking for convenient options. Manufacturers are responding to this trend by developing innovative products that meet the growing appetite for health-promoting ingredients.

Favorable government policies supporting dietary supplements are contributing to market growth. As consumers continue to prioritize health and wellness, the outlook for this market remains strong, with ongoing innovation and a shift towards sustainable sourcing further driving demand. Overall, the landscape is evolving, positioning omega-3s as a key component in the health and wellness sector.

U.S. DHA Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. DHA market report based on the source, & application:

• Source Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
• Marine
• Plant
• Micro-algae
• Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
• Pharmaceutical
• Nutraceutical

o Functional Food & Beverages"
"Organ Transplant Immunosuppressant Drugs Market Growth & Trends

The global organ transplant immunosuppressant drugs market size is estimated to reach USD 7.24 billion by 2030, registering a CAGR of 4.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing patient population requiring organ transplantations and increasing approval of novel products are the factors driving the market growth. However, the high procedural cost of transplantations, the disproportion in the supply and demand for organs, and uncertain reimbursement scenario are the major factors restraining the market growth.

According to the Health Resources & Services Administration and the U.S. Department of Health and Human Services, more than 113,000 people were in need of transplants as of January 2019 and 36,528 transplants were performed in 2018. Hence, there is huge demand for organ transplants that will further boost the market. Kidney transplant held the largest market share in the transplant segment and is expected to retain its leading position through the forecast period. This can be attributed to increasing demand and comparatively better availability of kidneys than other organs.

Among the drug classes, the calcineurin inhibitors are expected to dominate the global organ transplant immunosuppressant drugs market through the forecast period. There are two drugs in this drug class, Prograf (tacrolimus) and Neoral/Sandimmune (cyclosporine). Although these effective immunosuppressants have been used in kidney transplant recipients for more than 20 years, they hold extensive toxicity profiles. Asia Pacific is expected to show the highest CAGR, while North America is expected to hold the largest share during the forecast period.

Organ Transplant Immunosuppressant Drugs Market Report Highlights

• Calcineurin inhibitors are expected to command the largest market share in the drug class segment. Calcineurin inhibitors inhibit the activation action of T-cells of the immune system by the enzyme calcineurin.
• Calcineurin inhibitors such as tacrolimus and cyclosporine are the cornerstone of immunosuppression for kidney transplantation. In more than 85% cases of kidney transplant, tacrolimus is prescribed as a part of the patients’ maintenance immunosuppressive regimen.
• Based on transplant type, the kidney transplant held the largest market share of 49.1% in 2024, due to the increasing demand for kidney replacement procedures
• Asia Pacific regional market is expected to demonstrate the fastest growth over the forecast period due to rising per capita healthcare expenditure, improving healthcare infrastructure, and increasing demand for organ transplantations in the region.

Please note The report will be delivered in 2-3 business days upon order notification.